SWOG
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1956-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.swog.org
S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma
- Conditions
- Lymphoma
- Interventions
- First Posted Date
- 2005-05-04
- Last Posted Date
- 2014-10-01
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 34
- Registration Number
- NCT00109928
- Locations
- 🇺🇸
Decatur Memorial Hospital Cancer Care Institute, Decatur, Illinois, United States
🇺🇸Sparrow Regional Cancer Center, Lansing, Michigan, United States
🇺🇸Sletten Cancer Institute at Benefis Healthcare, Great Falls, Montana, United States
S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
- Conditions
- Leukemia
- Interventions
- Biological: filgrastimRadiation: radiation therapy
- First Posted Date
- 2005-05-04
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 79
- Registration Number
- NCT00109837
- Locations
- 🇺🇸
Providence Saint Joseph Medical Center - Burbank, Burbank, California, United States
🇺🇸Gibbs Regional Cancer Center at Spartanburg Regional Medical Center, Spartanburg, South Carolina, United States
🇺🇸Minor and James Medical, PLLC, Seattle, Washington, United States
S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma
- Conditions
- PlasmacytomaMultiple Myeloma
- Interventions
- Procedure: magnetic resonance imagingProcedure: positron emission tomography
- First Posted Date
- 2005-05-04
- Last Posted Date
- 2017-04-24
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 2
- Registration Number
- NCT00109889
- Locations
- 🇺🇸
Bozeman Deaconess Cancer Center, Bozeman, Montana, United States
🇺🇸CCOP - Montana Cancer Consortium, Billings, Montana, United States
🇺🇸Hematology-Oncology Centers of the Northern Rockies - Billings, Billings, Montana, United States
S0433 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
- Conditions
- Lymphoma
- Interventions
- Biological: rituximabRadiation: tositumomab and iodine I 131 tositumomab
- First Posted Date
- 2005-04-06
- Last Posted Date
- 2016-03-07
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 86
- Registration Number
- NCT00107380
- Locations
- 🇺🇸
CCOP - Montana Cancer Consortium, Billings, Montana, United States
🇺🇸Hematology-Oncology Centers of the Northern Rockies - Billings, Billings, Montana, United States
🇺🇸Northern Rockies Radiation Oncology Center, Billings, Montana, United States
S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer
- First Posted Date
- 2005-04-06
- Last Posted Date
- 2013-07-18
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 112
- Registration Number
- NCT00107276
- Locations
- 🇺🇸
Big Sky Oncology, Great Falls, Montana, United States
🇺🇸Great Falls Clinic - Main Facility, Great Falls, Montana, United States
🇺🇸Kaiser Permanente Medical Center - Redwood City, Redwood City, California, United States
S0423 Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic Chondrosarcoma
- First Posted Date
- 2005-04-06
- Last Posted Date
- 2012-01-18
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 75
- Registration Number
- NCT00107419
- Locations
- 🇺🇸
Carle Cancer Center at Carle Foundation Hospital, Urbana, Illinois, United States
🇺🇸CCOP - Carle Cancer Center, Urbana, Illinois, United States
🇺🇸Rush-Copley Cancer Care Center, Aurora, Illinois, United States
Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma
- Conditions
- Sarcoma
- First Posted Date
- 2005-03-04
- Last Posted Date
- 2013-06-24
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 40
- Registration Number
- NCT00104949
S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
- First Posted Date
- 2005-03-04
- Last Posted Date
- 2012-08-22
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 64
- Registration Number
- NCT00104988
- Locations
- 🇺🇸
CCOP - Upstate Carolina, Spartanburg, South Carolina, United States
🇺🇸U.T. Cancer Institute at University of Tennessee Medical Center, Knoxville, Tennessee, United States
🇺🇸Cottonwood Hospital Medical Center, Murray, Utah, United States
Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2005-02-08
- Last Posted Date
- 2013-06-24
- Lead Sponsor
- SWOG Cancer Research Network
- Registration Number
- NCT00103233
S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
- First Posted Date
- 2005-01-07
- Last Posted Date
- 2012-10-01
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 67
- Registration Number
- NCT00100789
- Locations
- 🇺🇸
Holland Community Hospital, Holland, Michigan, United States
🇺🇸University of Mississippi Medical Center, Jackson, Mississippi, United States
🇺🇸St. John's Regional Health Center, Springfield, Missouri, United States